Compare stocks

Zealand Pharma A/S is a biotechnology company headquartered in Copenhagen, Denmark, specializing in the discovery and development of peptide-based medicines. The company focuses on developing treatments for gastrointestinal and metabolic diseases, including obesity and diabetes. Its product portfolio includes innovative solutions like dasiglucagon, intended for severe hypoglycemia. Founded in 1998, Zealand Pharma leverages proprietary peptide platforms to address unmet medical needs. The company's strategic positioning involves strong partnerships and collaborations with pharmaceutical companies to advance its products through various stages of clinical development.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.